This session will review the indications, management and economics of ECMO as well as the implications of managing patiets with COVID -19.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Pablo Sanchez

Digital Moderators

Errol Bush

Presentations:

1. Extracorporeal Membrane Oxygenation in Lung Transplantation: Superior to Cardiopulmonary Bypass and Comparable to Off-Pump Strategy - Arvind Bussetty

2. Evaluation of Mortality and Charges in Post Cardiotomy Extracorporeal Support in the United States - Jahnavi Kakuturu

3. Proning in Patients with Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation is Safe and Feasible - Stephanie Chang

4. Break-even Cost and Center Volume Analysis Comparing Extracorporeal Membrane Oxygenation (ECMO) Nurse-led Program versus Perfusionist-led Program - Ankit Dhamija

5. Analysis of 153 consecutive patients with COVID-19 and Severe Pulmonary Compromise treated with Extracorporeal Membrane Oxygenation (ECMO): Outcomes and Trends Over Time - Jeffrey Jacobs

(Commercial Relationships: SpecialtyCare, Inc.: Consultant/Advisory Board)

6. Flying the plane while building it: Developing a research infrastructure during a changing pandemic - Brian Garibaldi

7. Round Table Discussion

Brian Garibaldi

Nader Moazami

Gary Schwartz

Zachary Kon (Commercial Relationships: Breethe/Abiomed: Consultant Advisory/Board, Speaker Honoraria, Ownership Interest; Medtronic: Consultant Advisory/Board, Speaker Honoraria)

Bryan Stanifer

Phillippe Lemaitre

J.W. Hayanga